Dehydration Severity Assessment, Oral Rehydration Therapy (ORT), and Intravenous Fluid Protocols

Acute Gastroenteritis and Dehydration: Severity Assessment, Oral Rehydration Therapy, and Intravenous Fluid Protocols

Acute gastroenteritis (AGE) remains one of the leading causes of paediatric morbidity, emergency department consultations, and hospital admissions globally and across Europe. AGE is defined as a diarrheal illness of rapid onset, with or without vomiting, fever, or abdominal pain, typically lasting less than 7 to 14 days. The primary pathophysiological consequence and principal driver of mortality in acute gastroenteritis is dehydration and electrolyte disturbance resulting from the loss of water, sodium, potassium, and bicarbonate in watery stools and emesis. Mastering the clinical evaluation of fluid volume depletion, the execution of Oral Rehydration Therapy (ORT), and the precise calculation of intravenous resuscitation and maintenance fluids is a core competency for the European Board of Paediatrics (EBP-EAP) examination.

---

Etiology and Pathophysiological Mechanisms

In European and industrialized settings, viruses account for over 70% to 80% of acute gastroenteritis episodes:

• Rotavirus: Historically the leading cause of severe dehydrating diarrhea in young children; incidence has declined markedly following the introduction of live-attenuated oral rotavirus vaccines (Rotarix, RotaTeq). Rotavirus infects mature enterocytes of the mid- and upper small-intestinal villi, causing blunting of villi, loss of brush-border disaccharidases (inducing secondary transient lactose malabsorption), and secretion of the viral enterotoxin NSP4, which triggers phospholipase C-dependent intracellular calcium release and active chloride secretion.
• Norovirus: Currently the predominant cause of both sporadic gastroenteritis and institutional outbreaks across all age groups. It exhibits high infectivity, environmental stability, and rapid genetic evolution.
• Enteric Adenoviruses (Serotypes 40/41), Astroviruses, and Sapoviruses: Common viral causes producing mild-to-moderate watery diarrhea.
• Bacterial Pathogens: (10–20% of cases) Include Campylobacter jejuni (most common bacterial cause in Europe, often associated with poultry ingestion), Salmonella enterica (non-typhoidal), Shigella sonnei, and Yersinia enterocolitica. Bacterial enteropathogens invade mucosal enterocytes or produce cytotoxic enterotoxins, often presenting with high fever, severe abdominal cramps, tenesmus, and dysentery (macroscopic blood, mucus, and leukocytes in stool).
• Shiga Toxin-producing Escherichia coli (STEC / EHEC, e.g., O157:H7): Causes hemorrhagic colitis and carries a high risk (10–15%) of precipitating Hemolytic Uremic Syndrome (HUS), characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury.

---

Clinical Assessment and Severity Grading of Dehydration

Accurate assessment of dehydration severity dictates the clinical setting (outpatient vs inpatient) and the route of rehydration (oral vs enteral via nasogastric tube vs intravenous). Clinical dehydration assessment correlates historical features, physical examination signs, and percentage of acute body weight loss.

                               [Clinical Signs of Dehydration]
                                              |
         +------------------------------------+------------------------------------+
         |                                    |                                    |
   [Mild (<5%)]                       [Moderate (5–9%)]                    [Severe (≥10%)]
   - Normal CRT (<2s)                 - Delayed CRT (2–3s)                 - Prolonged CRT (≥3s)
   - Moist mucous membranes           - Dry mucous membranes               - Parched/cracked mucosa
   - Normal skin turgor               - Decreased turgor (slow recoil)     - Skin tenting (>2s)
   - Normal eyes & fontanelle         - Sunken eyes & fontanelle           - Deeply sunken eyes
   - Alert, thirsty                   - Irritable, restless                - Lethargic, comatose
   - Normal pulses & BP               - Mild tachycardia                   - Thready pulse, shock

Clinical Dehydration Classification Scheme

---

Oral Rehydration Therapy (ORT) Protocol

Oral Rehydration Therapy (ORT) is the gold standard first-line treatment recommended by ESPGHAN, WHO, and AAP for infants and children with mild-to-moderate dehydration from acute gastroenteritis. ORT exploits the intact sodium-glucose cotransporter 1 (SGLT1) in the brush border of intestinal enterocytes: two sodium ions are cotransported with each glucose molecule, creating an osmotic gradient that drives passive water reabsorption across the luminal membrane even in the presence of severe secretory diarrhea.

Low-Osmolarity ORS Composition

Older WHO formulations (total osmolarity 311 mOsm/L, sodium 90 mmol/L) were associated with hypernatremia and prolonged diarrheal purging. Modern evidence supports low-osmolarity ORS (total osmolarity 245 mOsm/L), which reduces stool output by 20%, decreases vomiting by 30%, and lowers the need for rescue intravenous hydration by 33%.

• Sodium: 75 mmol/L (mEq/L) — ESPGHAN European formulation recommends 60 mmol/L (range 50–60)
• Glucose: 75 mmol/L (13.5 g/L)
• Potassium: 20 mmol/L
• Chloride: 65 mmol/L
• Citrate: 10 mmol/L
• Total Osmolarity: 245 mOsm/L

Clinical ORT Administration Regimen

• Rehydration Phase (First 4 Hours):
  • Mild Dehydration (<5%): Administer 50 mL/kg of low-osmolarity ORS orally over 4 hours.
  • Moderate Dehydration (5–9%): Administer 100 mL/kg of low-osmolarity ORS orally over 4 hours.
• Technique of Administration: Give small, frequent aliquots—typically 5 mL (one teaspoon or syringe) every 1 to 2 minutes. Rapid drinking from a bottle or cup distends the stomach and triggers the emetic reflex. If the infant vomits, wait 5 to 10 minutes, then resume administration at a slower rate (e.g., 2 to 3 mL every 2 minutes).
• Replacement of Ongoing Fluid Losses:
  • Replace each loose, watery stool with 10 mL/kg of ORS.
  • Replace each episode of significant vomiting with 2 to 5 mL/kg of ORS.
• Nasogastric (NG) Tube Rehydration: If oral administration fails due to persistent refusal or exhaustion, enteral rehydration via a fine-bore nasogastric tube at 15 to 25 mL/kg/h using an infusion pump is safer and more effective than proceeding directly to peripheral intravenous cannulation.
• Maintenance and Early Nutritional Re-feeding:
  • Breastfeeding should never be interrupted during ORT; breast milk provides protective antibodies, lactoferrin, and epidermal growth factor that accelerate mucosal repair.
  • In formula-fed and older children, age-appropriate solid feeding should be resumed immediately after the 4-hour rehydration phase is complete.
  • Diluting formula or using restrictive diets (such as the traditional BRAT diet: bananas, rice, applesauce, toast) is expressly discouraged, as it leads to prolonged hypocaloric malnutrition and delays enterocyte brush-border regeneration.

---

Indications and Protocols for Intravenous Fluid Resuscitation

Intravenous fluid therapy is indicated when enteral rehydration is either impossible, unsafe, or failing to keep pace with pathological fluid losses.

Indications for Intravenous Rehydration

1. Hypovolemic Shock: Decompensated (hypotension) or compensated shock (CRT ≥3 seconds, tachycardia, cool extremities, thready pulses).
2. Severe Dehydration (≥10%): Altered level of consciousness (lethargy, stupor, coma).
3. Persistent Emesis: Failure of supervised oral and, when safe, nasogastric ORS; consider single-dose ondansetron in appropriate children.
4. Failure of Enteral Therapy: Worsening dehydration or persistent inability to tolerate fluids via oral and nasogastric routes.
5. Paralytic Ileus, Abdominal Distension, or Acute Surgical Abdomen: Suspicion of intussusception, appendicitis, or toxic megacolon.
6. Severe Malabsorption or High Output: IV replacement may be needed when losses exceed tolerated enteral replacement; a high stool rate alone does not rule out ORT.

Phases of Intravenous Fluid Therapy

                       [Intravenous Fluid Resuscitation Protocol]
                                           |
         +---------------------------------+---------------------------------+
         |                                                                   |
  [Phase 1: Resuscitation]                                         [Phase 2: Deficit + Maintenance + Ongoing Losses]
  - 10 to 20 mL/kg Isotonic Balanced Crystalloid                    - Calculate Holliday-Segar Maintenance
    (Plasmalyte 148 / Ringer's Lactate / 0.9% Saline)               - Calculate Water Deficit (% Dehydration)
  - Infuse over 10 to 20 minutes (push in severe shock)             - Replace deficit over 24h (48h if hypernatremic)
  - Reassess vitals, CRT, and perfusion                             - Add 20 mmol/L KCl ONLY AFTER urine output established
  - Repeat bolus if shock persists (up to 40–60 mL/kg)

Phase 1: Rapid Restoration of Intravascular Volume (Emergency Bolus)

In the presence of shock or critical hypoperfusion, the immediate objective is expansion of the effective circulating arterial volume to preserve cerebral, coronary, and renal microperfusion.

• Fluid Type: Isotonic balanced crystalloid (e.g., Plasmalyte 148, Hartmann's solution, or Ringer's lactate) or 0.9% Sodium Chloride (isotonic saline). Balanced crystalloids are preferred in European guidelines to avoid hyperchloremic metabolic acidosis.
• Volume & Rate: 10 to 20 mL/kg administered as an intravenous or intraosseous bolus over 10 to 20 minutes.
• Immediate Reassessment: Evaluate heart rate, peripheral pulses, capillary refill time, and level of consciousness. If signs of hypoperfusion persist, repeat the 10 to 20 mL/kg bolus up to a cumulative volume of 40 to 60 mL/kg, while actively monitoring for signs of fluid overload (hepatomegaly, pulmonary crackles, gallop rhythm).

Phase 2: Deficit Replacement and Ongoing Maintenance Fluids

Once circulation is stable, prescribe remaining deficit + maintenance + ongoing losses. Replace continuing gastrointestinal losses separately, preferably using measured volumes, and reassess the fluid balance.

• 1. Calculation of Fluid Deficit: $\text{Deficit (mL)} = \% \text{ Dehydration} \times \text{Body Weight (kg)} \times 10$ Example: A 10 kg child with 8% dehydration has a total fluid deficit of $8 \times 10 \times 10 = 800\text{ mL}$. Any resuscitation bolus administered during Phase 1 is subtracted from this deficit.

• 2. Calculation of Daily Maintenance Fluids (Holliday-Segar Formula):

  • First 10 kg of body weight: $100\text{ mL/kg/day}$
  • Second 10 kg (11 to 20 kg): Add $50\text{ mL/kg/day}$ for each kilogram between 11 and 20 kg
  • Each kilogram above 20 kg: Add $20\text{ mL/kg/day}$ for each kilogram $>20\text{ kg}$ Hourly Maintenance Rule (4-2-1 Rule): $4\text{ mL/kg/h}$ for the first 10 kg, $2\text{ mL/kg/h}$ for 11–20 kg, and $1\text{ mL/kg/h}$ for each kg $>20\text{ kg}$.

• 3. Fluid Composition and Administration Schedule:

  • In isonatremic (Na 135–145 mmol/L) or hyponatremic (Na <135 mmol/L) dehydration: Replace the deficit plus maintenance over 24 hours (typically half administered over the first 8 hours, and the remaining half over the subsequent 16 hours) using an isotonic maintenance solution containing glucose (e.g., 0.9% NaCl with 5% Dextrose, or balanced paediatric maintenance solution).
  • Potassium Replacement: Add 20 to 40 mmol/L Potassium Chloride (KCl) to maintenance fluids strictly after the child has voided urine spontaneously and adequate renal function is confirmed. Adding KCl to intravenous fluids in an anuric child risks lethal hyperkalemia and ventricular arrhythmias.

---

Hypernatremic Dehydration Management

Hypernatremic dehydration (serum sodium >145 to 150 mmol/L) occurs in 5% to 10% of infants with acute gastroenteritis, typically when water losses exceed sodium losses (e.g., high-evaporative fever, tachypnea, ingestion of improperly concentrated formula, or high-solute solutions).

• Clinical Presentation: Intracellular water is drawn into the hypertonic extracellular space, preserving intravascular volume and blood pressure. Consequently, classical signs of dehydration appear deceptively delayed. Infants exhibit doughy or velvety skin turgor, a high-pitched shrill cry, extreme lethargy alternating with hyperirritability, hypertonia, hyperreflexia, and fever.
• Pathophysiology of Cerebral Injury: Hypertonicity causes brain cell dehydration and shrinkage, pulling cerebral bridging veins taut and risking subdural and subarachnoid hemorrhages, as well as dural sinus thrombosis. Over 24 to 48 hours, brain cells synthesize idiogenic intracellular osmoles (taurine, myo-inositol, betaine) to restore intracellular brain volume.
• Rehydration Strategy and Sodium Correction Rate: If intravascular volume is depleted, administer 10 to 20 mL/kg isotonic crystalloid to restore perfusion. Once stabilized, replace the remaining deficit slowly over about 48 hours, initially with 0.9% NaCl and 5% glucose plus maintenance and ongoing-loss replacement. Check sodium frequently; adjust with specialist advice if correction is too fast or inadequate. 0.45% saline is hypotonic, not interchangeable initial therapy.
• Safe Rate of Sodium Reduction: Serum sodium must not decrease by more than 0.5 mmol/L per hour, with a maximum decline of 10 to 12 mmol/L in 24 hours. Rapid reduction of extracellular tonicity causes rapid water influx into brain cells containing high idiogenic osmoles, triggering catastrophic cerebral edema, intractable seizures, and uncal herniation.

---

Pharmacological and Adjunctive Interventions

Oral Ondansetron

A single oral dose of ondansetron (selective $5\text{-}HT_3$ receptor antagonist) is recommended in children aged 6 months to 10 years with mild-to-moderate dehydration who have persistent vomiting that hampers ORT.

• Dosing Protocol: Weight-based single oral dose: 8 to 15 kg: 2 mg; 15 to 30 kg: 4 mg; >30 kg: 8 mg (or approximately 0.15 mg/kg).
• Clinical Benefits: Significantly reduces persistent emesis, increases the success rate of ORT, halves the need for intravenous fluid administration, and decreases emergency department admission rates.
• Adverse Effects: May increase diarrhoea transiently; this is usually mild and self-limited, lasting less than 48 hours.

Antimicrobial Therapy in Acute Gastroenteritis

Routine antibiotic administration in acute watery gastroenteritis is not recommended and is often harmful.

• Shiga Toxin-producing E. coli (STEC): Antibiotic therapy is strictly contraindicated because bactericidal agents induce the bacterial SOS response, triggering massive lysis of bacteria and surge in systemic Shiga toxin release, substantially increasing the risk of Hemolytic Uremic Syndrome (HUS).
• Non-typhoidal Salmonella: Antibiotics prolong fecal shedding, induce asymptomatic carrier states, and increase relapse rates. Antibiotics (IV ceftriaxone or oral ciprofloxacin/azithromycin) are strictly reserved for infants under 3 months, immunocompromised hosts, sickle cell disease (risk of Salmonella osteomyelitis), or systemic bacteremic dissemination.
• Specific Antibiotic Indications: Definitively indicated for culture-proven Shigella dysentery (azithromycin or ceftriaxone to reduce transmission and clinical duration), selected Campylobacter enteritis (especially dysentery, severe/high-risk disease or transmission control; azithromycin, with greatest benefit when started early), Vibrio cholerae, and severe Clostridioides difficile enterocolitis (oral vancomycin or fidaxomicin).

Micronutrient Supplementation and Probiotics

• Zinc Supplementation: WHO 2024 suggests 5 mg/day for up to 14 days for children up to 10 years with acute watery or persistent diarrhoea. UNICEF July 2026 advises continued 20 mg/day for 14 days while 5-mg products are unavailable. Zinc can shorten diarrhoea, particularly in deficient populations; ESPGHAN does not recommend routine supplementation where zinc deficiency is rare.
• Probiotics: Active strains with documented efficacy in ESPGHAN clinical practice guidelines include Lactobacillus rhamnosus GG and Saccharomyces boulardii. When administered early at doses $\ge 10^{10}\text{ CFU/day}$, they reduce the duration of viral diarrhea by approximately 24 hours.